Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.90%
1,092.81
+9.77
+0.90%
1,083.041,082.631,094.711,080.59
SIXC
Communications
SIXC
Communications
SIXC
+0.23%
603.74
+1.36
+0.23%
602.38602.38604.95599.75
SIXE
Energy
SIXE
Energy
SIXE
+1.00%
1,255.20
+12.37
+1.00%
1,242.831,229.311,256.581,220.51
SIXI
Industrials
SIXI
Industrials
SIXI
+2.25%
1,752.39
+38.57
+2.25%
1,713.821,715.471,754.201,715.47
SIXM
Financials
SIXM
Financials
SIXM
+0.26%
641.67
+1.68
+0.26%
639.99636.98642.82631.81
SIXR
Staples
SIXR
Staples
SIXR
+1.37%
848.90
+11.44
+1.37%
837.46840.30852.15840.30
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.18%
216.74
+2.52
+1.18%
214.22214.22217.26214.05
SIXT
Technology
SIXT
Technology
SIXT
-0.56%
3,186.28
-18.10
-0.56%
3,204.383,215.043,215.043,159.90
SIXU
Utilities
SIXU
Utilities
SIXU
+2.00%
943.91
+18.53
+2.00%
925.38927.91948.11927.91
SIXV
Health care
SIXV
Health care
SIXV
+2.13%
1,473.45
+30.74
+2.13%
1,442.711,443.011,476.181,443.01
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.12%
2,364.12
+2.78
+0.12%
2,361.342,391.002,395.822,354.52
XLO:NASDAQ
Xilio Therapeutics Inc
$7.85
+0.77%
(+0.060) 1D
Apr 30, 10:06:48 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XLO...
Open
$7.74
High
$7.85
Low
$7.74
Mkt. cap
46.97M
Avg. vol.
44.76K
Volume
2.16K
52-wk high
$16.52
52-wk low
$6.47
EPS
-$4.19
Beta
-0.13
Shares outstanding
5.78M
No. of employees
76
News stories
From sources across the web
About Xilio Therapeutics Inc
CEO-
Employees76
Founded2016
Headquarters-
SectorBiotechnology
Next call in 14 days
Thu, May 14, 9:30 AM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-2.24 est.)USD
Revenue / Estimate
-/ (8.52M est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.93M
8.08M
19.07M
13.69M
Cost of goods sold
-
15.33M
14.32M
-37.92M
Cost of revenue
-
15.33M
14.32M
-37.92M
Research and development expenses
8.27M
-
-
56.04M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.52M
7.12M
6.67M
7.40M
Operating expense
16.78M
7.12M
6.67M
63.44M
Total operating expenses
16.78M
22.45M
21.00M
25.52M
Operating income
-13.85M
-14.37M
-1.93M
-11.84M
Other non operating income
586.00K
-1.48M
-14.36M
24.70M
EBT including unusual items
-13.26M
-15.84M
-16.29M
10.36M
EBT excluding unusual items
-13.26M
-15.84M
-16.29M
10.36M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-13.26M
-15.84M
-16.29M
10.36M
Net profit margin
-452.73%
-195.99%
-85.42%
75.70%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-2.50M
Net interest expenses
-
-
-
-2.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.35M
-13.98M
-1.59M
-11.51M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more